SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chiao-Fang Teng, Wen-Chuan Hsieh, Ching-Wen Yang, Hui-Min Su, Ting-Fen Tsai, Wang-Chou Sung, Wenya Huang, Ih-Jen Su, A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis, Molecular Carcinogenesis, 2015, 54, 6
  2. 2
    Chiao-Fang Teng, Han-Chieh Wu, Wen-Chuan Hsieh, Hung-Wen Tsai, Ih-Jen Su, J.-H. J. Ou, Activation of ATP Citrate Lyase by mTOR Signal Induces Disturbed Lipid Metabolism in Hepatitis B Virus Pre-S2 Mutant Tumorigenesis, Journal of Virology, 2015, 89, 1, 605

    CrossRef

  3. 3
    Pingping Zhang, Fang Li, Na Li, Qianqian Zhu, Cuiling Yang, Qunying Han, Jinghong Chen, Yi Lv, Ling Yu, Ping Wei, Zhengwen Liu, Genetic variations of SOCS1 are associated with chronic hepatitis B virus infection, Human Immunology, 2014, 75, 8, 709

    CrossRef

  4. 4
    Han-Chieh Wu, Hung-Wen Tsai, Chiao-Fang Teng, Wen-Chuan Hsieh, Yih-Jyh Lin, Lily Hui-Ching Wang, Quan Yuan, Ih-Jen Su, Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis, Human Pathology, 2014, 45, 6, 1294

    CrossRef

  5. 5
    Y.-Q. Wang, Y.-F. Ren, Y.-J. Song, Y.-F. Xue, X.-J. Zhang, S.-T. Cao, Z.-J. Deng, J. Wu, L. Chen, G. Li, K.-Q. Shi, Y.-P. Chen, H. Ren, A.-L. Huang, K.-F. Tang, MicroRNA-581 promotes hepatitis B virus surface antigen expression by targeting Dicer and EDEM1, Carcinogenesis, 2014, 35, 9, 2127

    CrossRef

  6. 6
    Zhuo Wang, Wei Jin, Hongchuan Jin, Xian Wang, mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment, BioMed Research International, 2014, 2014, 1

    CrossRef

  7. 7
    Kung-Chao Chang, Yao Chang, Lily Hui-Ching Wang, Hung-Wen Tsai, Wenya Huang, Ih-Jen Su, Pathogenesis of virus-associated human cancers: Epstein–Barr virus and hepatitis B virus as two examples, Journal of the Formosan Medical Association, 2014, 113, 9, 581

    CrossRef

  8. 8
    Lothar Bergmann, Luise Maute, Michael Guschmann, Temsirolimus for advanced renal cell carcinoma, Expert Review of Anticancer Therapy, 2014, 14, 1, 9

    CrossRef

  9. 9
    Eleonora Teplinsky, Derrick Cheung, Ilan Weisberg, Ramon E. A. Jacobs, Martin Wolff, James Park, Kent Friedman, Franco Muggia, Komal Jhaveri, Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature, Breast Cancer Research and Treatment, 2013, 141, 2, 167

    CrossRef

  10. 10
    Shinta Mizuno, Yoshiyuki Yamagishi, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Mai Katahira, Aya Sasaki, Michiie Sakamoto, Hidekazu Suzuki, Takanori Kanai, Toshifumi Hibi, Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier, Clinical Journal of Gastroenterology, 2013, 6, 2, 188

    CrossRef

  11. You have free access to this content11
    H.-S. Shiah, C.-Y. Chen, C.-Y. Dai, C.-F. Hsiao, Y.-J. Lin, W.-C. Su, J.-Y. Chang, J. Whang-Peng, P.-W. Lin, J.-D. Huang, L.-T. Chen, Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2013, 37, 1
  12. 12
    Kenya Yamanaka, Marius Petrulionis, Shibo Lin, Chao Gao, Uwe Galli, Susanne Richter, Susanne Winkler, Philipp Houben, Daniel Schultze, Etsuro Hatano, Peter Schemmer, Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma – systematic review and meta-analysis, Cancer Medicine, 2013, 2, 6
  13. 13
    L. H.-C. Wang, W. Huang, M.-D. Lai, I.-J. Su, Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus Pre-S2 mutants and its implication in hepatocarcinogenesis, Carcinogenesis, 2012, 33, 2, 466

    CrossRef

  14. 14
    Hildegard I. D. Mack, Karl Munger, Modulation of Autophagy-Like Processes by Tumor Viruses, Cells, 2012, 1, 4, 204

    CrossRef

  15. 15
    Ronald M. Bukowski, Temsirolimus : a safety and efficacy review, Expert Opinion on Drug Safety, 2012, 11, 5, 861

    CrossRef

  16. 16
    Shengjie Zhang, Tingting Jiang, Lifeng Feng, Jie Sun, Haiqi Lu, Qinchuan Wang, Min Pan, Dongsheng Huang, Xian Wang, Linbo Wang, Hongchuan Jin, Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha, Journal of Molecular Medicine, 2012, 90, 9, 1069

    CrossRef

  17. 17
    Pavel Strnad, Renwar Nuraldeen, Nurdan Guldiken, Daniel Hartmann, Vineet Mahajan, Helmut Denk, Johannes Haybaeck, Broad Spectrum of Hepatocyte Inclusions in Humans, Animals, and Experimental Models, Comprehensive Physiology,